Explore Mutual Funds

HDFC Pharma and Healthcare Fund-Reg(G)

As on Oct-29-2026 change fund
21.08  up0.14 (0.67%)
BUY

fund objective

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.

riskometer

Investors understand that their principal will be at very high risk

5-Years History
financial year2025-20262024-20252023-2024
NAV in Rs (as on 31-Mar)16.9815.9212.29
Net Assets(Rs Crores) (as on 31-Mar) 1976.86 1634.08 800.65
Scheme Returns(%)(Absolute)8.4828.3523.30
B'mark Returns(%)(Absolute)NANANA
Category Rank7/1201/10266/90
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2026-202720.163.82NANA
2025-20265.72-0.422.80-1.46
2024-20256.7523.015.51-6.47
2023-2024NANANA8.50
Top 10 holdings
company (%)
Divi's Laboratories Ltd.9.39 
Sun Pharmaceutical Industries...8.28 
Alkem Laboratories Ltd.4.64 
Cipla Ltd.4.15 
Apollo Hospitals Enterprise Ltd.3.69 
Torrent Pharmaceuticals Ltd.3.65 
Max Healthcare Institute Ltd.3.61 
Aster DM Quality Care Ltd.3.56 
Lupin Ltd.3.55 
Neuland Laboratories Ltd.3.24 

Category

Sector Funds

Launch Date

04-Oct-23

Scheme Benchmark

NA

AUM ( in Cr.)

3,501.37

portfolio price to book value

8.8

investing style?

Mid Growth

fund manager?

Nikhil Mathur

expense ratio %

2.11

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs70.71
Hospital & Healthcare Services22.13
Medical Equipment/Supplies/Accessories2.36
Trading1.56

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparison with similar schemes
scheme name investment style inception date AUM in Cr. 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
HDFC Pharma and Healthcare Fund-Reg(G)Mid-Growth 04-Oct-20233,501.3721.2828.88NANA27.63BUY
UTI Healthcare Fund-Reg(G)Mid-Growth 01-Aug-20051,429.8412.1922.3215.0813.2717.86BUY
DSP Healthcare Fund-Reg(G)Mid-Growth 30-Nov-20183,750.0413.9020.1014.70NA20.84BUY
Tata India Pharma & Healthcare Fund-Reg(G)Mid-Growth 28-Dec-20151,511.491.9217.3513.1012.8011.22BUY
disclaimer

Finmoksha financial services, is an AMFI registered distributor with ARN No. 143367 through its proprietor Gopal Kumar Agrawal

The firm does not furnish any guaranties, warranties or representations, express or implied, on products offered through the Finmoksha platform. The firm accepts no liability for any damages or losses however caused, in connection with investments made through the platform. Terms and conditions of the platform are applicable at all times.

Mutual fund and other investments are always subject to market risks. Please read all, Scheme Information Documents (SID), Key Information Memorandum (KIM), Addendums (if any) issued thereto from time to time and any other related documents or information carefully before investing. Past performance is not indicative or assurance of future performance or returns. Please consider your specific investment requirements, risk appetite and time horizon before choosing a scheme of mutual fund or any other investment.

ARN No. 143367    

Copyrights © 2018 Finmoksha Financial Services. All Right Reserved
Designed, Developed & Content Powered By ●●● Accord Fintech Pvt. Ltd.